Evogene (EVGN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.86
• Market Cap: $8.06M
• EPS: $-1.10
• 52-Week High: $2.42
• 52-Week Low: $0.81

Market Sentiment

Evogene currently has a Bullish sentiment score of 0.39.

About Evogene

Evogene Ltd. is a pioneering computational biology company based in Rehovot, Israel, specializing in the development of sustainable agricultural solutions through advanced data-driven methodologies. Utilizing its proprietary technology platforms, Evogene focuses on biotechnology applications that enhance crop productivity and resilience, ultimately addressing the challenges of food security in a changing climate. The company's innovative approach leverages genomic data to discover and optimiz...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Evogene and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EVGN pay dividends?

Evogene (EVGN) does not currently pay a regular dividend.

What is EVGN's market cap?

Evogene (EVGN) has a market capitalization of $8.06M with a current stock price of $0.86.